Medication for Opioid Use Disorder Training

Thursday, May 9, 2024, 12:00 AM - Friday, April 30, 2027, 11:45 PM


AMA PRA Category 1 Credits™ (1.75 hours), DEA MATE Act (1.75 hours), Non-Physician Attendance (1.75 hours), Pain and Symptom Management (1.75 hours)

Participants attending this activity will be able to explain and illustrate the fundamentals of medications for opioid use disorder and successfully and safely prescribe medications for opioid use disorder.

1. Understand that opioid use disorder is a medical illness and identify differences between dependence and addiction.
2. Identify the differences between medications for opioid use disorder and implement strategies to treat the disorder.
3. Describe and address the indications, dosing algorithms, potential complications, and components of successful buprenorphine administration and referral system in the emergency department.
4. Manage acute pain for patients with opioid use disorder.
5. Understand and implement harm reduction strategies from the emergency department, including rationale and evidence for community naloxone distribution.
6. Describe, utilize and act according to the legal and regulatory consideration related to buprenorphine prescribing.

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the University of Michigan Medical School and OPEN / University of Michigan School of Nursing . The University of Michigan Medical School is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Credit Designation

AMA PRA Category 1 Credit
The University of Michigan Medical School designates this enduring material for a maximum of 1.75 AMA PRA Category 1 Credit(s) ™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Original Release: 05/09/2024
Expiration: 04/30/2027

Material References (pdf)

Accessibility Statement: The University of Michigan Medical School is committed to ensuring that its programs, services, goods and facilities are accessible to individuals with disabilities as specified under Section 504 of the Rehabilitation Act of 1973 and the Americans with Disabilities Amendments Act of 2008.  If you have needs that require special accommodations, including dietary concerns, please contact the CME Activity Coordinator.

Mitigation of Relevant Financial Relationships

The University of Michigan Medical School adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CE activity, including faculty, planners, or others are required to disclose all relevant financial relationships with ineligible entities.

• None of the planners or presenters for this educational activity have relevant financial relationship(s) to disclose with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.